Recent Advances in Liver Resection for Hepatocellular Carcinoma

Frontiers in Surgery

Volumn 1, Issue , 2014, Pages

  Morise, Zenichi ^a   Kawabe, Norihiko ^a   Tomishige, Hirokazu ^a   Nagata, Hidetoshi ^a   Kawase, Jin ^a   Arakawa, Satoshi ^a   Yoshida, Rie ^a   Isetani, Masashi ^a  

^a FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

3 dimensional computed tomography; chemotherapy; hepatocellular carcinoma; laparoscopic hepatectomy; liver resection

Indexed keywords

EID: 85079383406     PISSN: None     EISSN: 2296875X     Source Type: Journal    
DOI: 10.3389/fsurg.2014.00021     Document Type: Review

References (103)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer (2010) 127:2893–917.10.1002/ijc.2551621351269
2. Rahbari NN, Mehrabi A, Mollberg NM, Muller SA, Koch M, Buchler MW, et al. Hepatocellular carcinoma: current management and perspectives for the future. Ann Surg (2011) 253:453–69.10.1097/SLA.0b013e31820d944f21263310
3. El-Serag HB, Marrero JA, Rudolph L, Reddy KR. Diagnosis and treatment of hepatocellular carcinoma. Gastroenterology (2008) 134:1752–63.10.1053/j.gastro.2008.02.090
4. Forner A, Reig ME, de Lope CR, Bruix J. Current strategy for staging and treatment: the BCLC update and future prospects. Semin Liver Dis (2010) 30:61–74.10.1055/s-0030-124713320175034
5. Torzilli G, Belghiti J, Kokudo N, Takayama T, Capussotti L, Nuzzo G, et al. A snapshot of the effective indications and results of surgery for hepatocellular carcinoma in tertiary referral centers: is it adherent to the EASL/AASLD recommendations?: an observational study of the HCC East-West study group. Ann Surg (2013) 257:929–37.10.1097/SLA.0b013e31828329b8
6. World Consensus Conference on Laparoscopic Surgery. The international position on laparoscopic liver surgery: the Louisville statement, 2008. Ann Surg (2009) 250(5):825–30.10.1097/SLA.0b013e3181b3b2d819916210
7. Nagano H, Miyamoto A, Wada H, Ota H, Marubashi S, Takeda Y, et al. Interferon-alpha and 5-fluorouracil combination therapy after palliative hepatic resection in patients with advanced hepatocellular carcinoma, portal venous tumor thrombus in the major trunk, and multiple nodules. Cancer (2007) 110(11):2493–501.10.1002/cncr.23033
8. Ikai I, Itai Y, Okita K, Omata M, Kojiro M, Kobayashi K, et al. Report of the 15th follow-up survey of primary liver cancer. Hepatol Res (2004) 28:21–9.10.1016/j.hepres.2003.08.00214734147
9. Imamura H, Matsuyama Y, Miyagawa Y, Ishida K, Shimada R, Miyagawa S, et al. Prognostic significance of anatomical resection and des-gamma-carboxy prothrombin in patients with hepatocellular carcinoma. Br J Surg (1999) 86:1032–8.10.1046/j.1365-2168.1999.01185.x10460639
10. Wakai T, Shirai Y, Sakata J, Kaneko K, Cruz PV, Akazawa K, et al. Anatomic resection independently improves long-term survival in patients with T1-T2 hepatocellular carcinoma. Ann Surg Oncol (2007) 14:1356–65.10.1245/s10434-006-9318-z17252289
11. Roayaie S, Blume IN, Thung SN, Guido M, Fiel MI, Hiotis S, et al. A system of classifying microvascular invasion to predict outcome after resection in patients with hepatocellular carcinoma. Gastroenterology (2009) 137:850–5.10.1053/j.gastro.2009.06.00319524573
12. Hoeper MM, Krowka MJ, Strassburg CP. Portopulmonary hypertension and hepatopulmonary syndrome. Lancet (2004) 363(9419):1461–8.10.1016/S0140-6736(04)16107-2
13. Ziser A, Plevak DJ, Wiesner RH, Rakela J, Offord KP, Brown DL. Morbidity and mortality in cirrhotic patients undergoing anesthesia and surgery. Anesthesiology (1999) 90(1):42–53.10.1097/00000542-199901000-00008
14. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg (1973) 60:646–9.10.1002/bjs.1800600817
15. Mansour A, Watson W, Shayani V, Pickleman J. Abdominal operations in patients with cirrhosis: still a major surgical challenge. Surgery (1997) 122(4):730–5.10.1016/S0039-6060(97)90080-59347849
16. Fuks D, Dokmak S, Paradis V, Diouf M, Durand F, Belghiti J. Benefit of initial resection of hepatocellular carcinoma followed by transplantation in case of recurrence: an intention-to-treat analysis. Hepatology (2012) 55:132–40.10.1002/hep.2468021932387
17. Poon RT, Fan ST, Lo CM, Liu CL, Wong J. Long-term survival and pattern of recurrence after resection of small hepatocellular carcinoma in patients with preserved liver function: implications for a strategy of salvage transplantation. Ann Surg (2002) 235:373–82.10.1097/00000658-200203000-0000911882759
18. Ishizawa T, Hasegawa K, Aoki T, Takahashi M, Inoue Y, Sano K, et al. Neither multiple tumors nor portal hypertension are surgical contraindications for hepatocellular carcinoma. Gastroenterology (2008) 134:1908–16.10.1053/j.gastro.2008.02.09118549877
19. Makuuchi M, Sano K. The surgical approach to HCC: our progress and results in Japan. Liver Transpl (2004) 10:S46–52.10.1002/lt.2004414762839
20. Farges O, Malassagne B, Flejou JF, Balzan S, Sauvanet A, Belghiti J. Risk of major liver resection in patients with underlying chronic liver disease: a reappraisal. Ann Surg (1999) 229:210–5.10.1097/00000658-199902000-0000810024102
21. Belghiti J, Regimbeau JM, Durand F, Kianmanesh AR, Dondero F, Terris B, et al. Resection of hepatocellular carcinoma: a European experience on 328 cases. Hepatogastroenterology (2002) 49:41–6.11941981
22. Torzilli G, Makuuchi M, Inoue K, Takayama T, Sakamoto Y, Sugawara Y, et al. No-mortality liver resection for hepatocellular carcinoma in cirrhotic and noncirrhotic patients: is there a way? A prospective analysis of our approach. Arch Surg (1999) 134:984–92.10.1001/archsurg.134.9.98410487594
23. Wakabayashi H, Ishimura K, Izuishi K, Karasawa Y, Maeta H. Evaluation of liver function for hepatic resection for hepatocellular carcinoma in the liver with damaged parenchyma. J Surg Res (2004) 116:248–52.10.1016/j.jss.2003.09.01515013363
24. Fan ST, Lai EC, Lo CM, Ng IO, Wong J. Hospital mortality of major hepatectomy for hepatocellular carcinoma associated with cirrhosis. Arch Surg (1995) 130:198–203.10.1001/archsurg.1995.014300200880177848092
25. Lam CM, Fan ST, Lo CM, Wong J. Major hepatectomy for hepatocellular carcinoma in patients with an unsatisfactory indocyanine green clearance test. Br J Surg (1999) 86:1012–7.10.1046/j.1365-2168.1999.01204.x10460635
26. Fan ST. Liver functional reserve estimation: state of the art and relevance for local treatments: the Eastern perspective. J Hepatobiliary Pancreat Sci (2010) 17:380–4.10.1007/s00534-009-0229-919865790
27. Belli G, Fantini C, Belli A, Limongelli P. Laparoscopic liver resection for hepatocellular carcinoma in cirrhosis: longterm outcomes. Dig Surg (2011) 28:134–40.10.1159/00032382421540599
28. Morise Z, Kawabe N, Kawase J, Tomishige H, Nagata H, Ohshima H, et al. Pure laparoscopic hepatectomy for hepatocellular carcinoma with chronic liver disease. World J Hepatol (2013) 5(9):487–95.10.4254/wjh.v5.i9.48724073300
29. Hsu KY, Chau GY, Lui WY, Tsay SH, King KL, Wu CW. Predicting morbidity and mortality after hepatic resection in patients with hepatocellular carcinoma: the role of model for end-stage liver disease score. World J Surg (2009) 33:2412–9.10.1007/s00268-009-0202-419756859
30. Delis SG, Bakoyiannis A, Biliatis I, Athanassiou K, Tassopoulos N, Dervenis C. Model for end-stage liver disease (MELD) score, as a prognostic factor for post-operative morbidity and mortality in cirrhotic patients, undergoing hepatectomy for hepatocellular carcinoma. HPB (Oxford) (2009) 11:351–7.10.1111/j.1477-2574.2009.00067.x19718364
31. Yamakado K, Takeda K, Matsumura K, Nakatsuka A, Hirano T, Kato N, et al. Regeneration of the un-embolized liver parenchyma following portal vein embolization. J Hepatol (1997) 27:871–80.10.1016/S0168-8278(97)80325-X9382975
32. Ogata S, Belghiti J, Farges O, Varma D, Sibert A, Vilgrain V. Sequential arterial and portal vein embolizations before right hepatectomy in patients with cirrhosis and hepatocellular carcinoma. Br J Surg (2006) 93:1091–8.10.1002/bjs.534116779884
33. Yoo H, Kim JH, Ko GY, Kim KW, Gwon DI, Lee SG, et al. Sequential transcatheter arterial chemoembolization and portal vein embolization versus portal vein embolization only before major hepatectomy for patients with hepatocellular carcinoma. Ann Surg Oncol (2011) 18:1251–7.10.1245/s10434-010-1423-321069467
34. Truant S, Oberlin O, Sergent G, Lebuffe G, Gambiez L, Ernst O, et al. Remnant liver volume to body weight ratio > or =0.5%: a new cut-off to estimate postoperative risks after extended liver resection in noncirrhotic liver. J Am Coll Surg (2007) 204:22–33.10.1016/j.jamcollsurg.2006.09.00717189109
35. Chun YS, Ribero D, Abdalla EK, Madoff DC, Mortenson MM, Wei SH, et al. Comparison of two methods of future liver remnant volume measurement. J Gastrointest Surg (2008) 12:123–8.10.1007/s11605-007-0323-817924174
36. Farges O, Belghiti J, Kianmanesh R, Regimbeau JM, Santoro R, Vilgrain V, et al. Portal vein embolization before right hepatectomy: prospective clinical trial. Ann Surg (2003) 237:208–17.10.1097/00000658-200302000-0001012560779
37. Ueno S, Kubo F, Sakoda M, Hiwatashi K, Tateno T, Mataki Y, et al. Efficacy of anatomic resection vs nonanatomic resection for small nodular hepatocellular carcinoma based on gross classification. J Hepatobiliary Pancreat Surg (2008) 15:493–500.10.1007/s00534-007-1312-818836803
38. Shi M, Guo RP, Lin XJ, Zhang YQ, Chen MS, Zhang CQ, et al. Partial hepatectomy with wide versus narrow resection margin for solitary hepatocellular carcinoma: a prospective randomized trial. Ann Surg (2007) 245:36–43.10.1097/01.sla.0000231758.07868.7117197963
39. Arii S, Tanaka S, Mitsunori Y, Nakamura N, Kudo A, Noguchi N, et al. Surgical strategies for hepatocellular carcinoma with special reference to anatomical hepatic resection and intraoperative contrast-enhanced ultrasonography. Oncology (2010) 78(Suppl 1):125–30.10.1159/00031524020616594
40. Poon RT, Fan ST, Ng IO, Lo CM, Liu CL, Wong J. Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma. Cancer (2000) 89:500–7.10.1002/1097-0142(20000801)89:3<500::AID-CNCR4>3.0.CO;2-O10931448
41. Radtke A, Sotiropoulos GC, Molmenti EP, Schroeder T, Peitgen HO, Frilling A, et al. Computer-assisted surgery planning for complex liver resections: when is it helpful? A single-center experience over an 8-year period. Ann Surg (2010) 252:876–83.10.1097/SLA.0b013e3181fdd01221037445
42. Gagner M, Rheault M, Dubuc J. Laparoscopic partial hepatectomy for liver tumor. Surg Endosc (1992) 6:97–8.
43. Kaneko H, Tsuchiya M, Otsuka Y, Yajima S, Minagawa T, Watanabe M, et al. Laparoscopic hepatectomy for hepatocellular carcinoma in cirrhotic patients. J Hepatobiliary Pancreat Surg (2009) 16(4):433–8.10.1007/s00534-009-0123-519458892
44. Mirnezami R, Mirnezami AH, Chandrakumaran K, Abu Hilal M, Pearce NW, Primrose JN, et al. Short- and long-term outcomes after laparoscopic and open hepatic resection: systematic review and meta-analysis. HPB (Oxford) (2011) 13(5):295–308.10.1111/j.1477-2574.2011.00295.x21492329
45. Tsuchiya M, Otsuka Y, Tamura A, Nitta H, Sasaki A, Wakabayashi G, et al. Status of endoscopic liver surgery in Japan: a questionnaire survey conducted by the Japanese endoscopic liver surgery study group. J Hepatobiliary Pancreat Surg (2009) 16(4):405–9.10.1007/s00534-009-0119-119458895
46. Viganò L, Tayar C, Laurent A, Cherqui D. Laparoscopic liver resection: a systematic review. J Hepatobiliary Pancreat Surg (2009) 16(4):410–21.10.1007/s00534-009-0120-819495556
47. Belghiti J, Hiramatsu K, Benoist S, Massault P, Sauvanet A, Farges O. Seven hundred forty-seven hepatectomies in the 1990s: an update to evaluate the actual risk of liver resection. J Am Coll Surg (2000) 191(1):38.10.1016/S1072-7515(00)00261-110898182
48. Lai EC, Fan ST, Lo CM, Chu KM, Liu CL, Wong J. Hepatic resection for hepatocellular carcinoma. An audit of 343 patients. Ann Surg (1995) 221(3):291–8.10.1097/00000658-199503000-000127717783
49. Morise Z. Pure laparoscopic hepatectomy for HCC patients. In: Lau WY, editor. Hepatocellular Carcinoma – Clinical Research. Zagreb: InTech (2012). p. 183–96.
50. Chen HY, Juan CC, Ker CG. Laparoscopic liver surgery for patients with hepatocellular carcinoma. Ann Surg Oncol (2008) 15(3):800–6.10.1245/s10434-007-9749-118165879
51. Dagher I, Lainas P, Carloni A, Caillard C, Champault A, Smadja C, et al. Laparoscopic liver resection for hepatocellular carcinoma. Surg Endosc (2008) 22(2):372–8.10.1007/s00464-007-9487-217704878
52. Kaneko H, Takagi S, Otsuka Y, Tsuchiya M, Tamura A, Katagiri T, et al. Laparoscopic liver resection of hepatocellular carcinoma. Am J Surg (2005) 189(2):190–4.10.1016/j.amjsurg.2004.09.010
53. Cherqui D, Laurent A, Tayar C, Chang S, Van Nhieu JT, Loriau J, et al. Laparoscopic liver resection for peripheral hepatocellular carcinoma in patients with chronic liver disease: midterm results and perspectives. Ann Surg (2006) 243(4):499–506.10.1097/01.sla.0000206017.29651.9916552201
54. Shimada M, Hashizume M, Maehara S, Tsujita E, Rikimaru T, Yamashita Y, et al. Laparoscopic hepatectomy for hepatocellular carcinoma. Surg Endosc (2001) 15(6):541–4.10.1007/s004640080099
55. Sarpel U, Hefti MM, Wisnievsky JP, Roayaie S, Schwartz ME, Labow DM. Outcome for patients treated with laparoscopic versus open resection of hepatocellular carcinoma: case-matched analysis. Ann Surg Oncol (2009) 16:1572–7.10.1245/s10434-009-0414-819259738
56. Hu BS, Chen K, Tan HM, Ding XM, Tan JW. Comparison of laparoscopic vs open liver lobectomy (segmentectomy) for hepatocellular carcinoma. World J Gastroenterol (2011) 17:4725–8.10.3748/wjg.v17.i42.472522180716
57. Ker CG, Chen JS, Kuo KK, Chuang SC, Wang SJ, Chang WC, et al. Liver surgery for hepatocellular carcinoma: laparoscopic versus open approach. Int J Hepatol (2011) 2011:596792.10.4061/2011/596792
58. Endo Y, Ohta M, Sasaki A, Kai S, Eguchi H, Iwaki K, et al. A comparative study of the long-term outcomes after laparoscopy-assisted and open left lateral hepatectomy for hepatocellular carcinoma. Surg Laparosc Endosc Percutan Tech (2009) 19:e171–4.10.1097/SLE.0b013e3181bc409119851245
59. Nguyen KT, Marsh JW, Tsung A, Steel JJ, Gamblin TC, Geller DA. Comparative benefits of laparoscopic vs open hepatic resection: a critical appraisal. Arch Surg (2011) 146:348–56.10.1001/archsurg.2010.24821079109
60. Tranchart H, Di Giuro G, Lainas P, Roudie J, Agostini H, Franco D, et al. Laparoscopic resection for hepatocellular carcinoma: a matched-pair comparative study. Surg Endosc (2010) 24(5):1170–6.10.1007/s00464-009-0745-319915908
61. Morise Z, Sugioka A, Kawabe N, Umemoto S, Nagata H, Ohshima H, et al. Pure laparoscopic hepatectomy for hepatocellular carcinoma patients with severe liver cirrhosis. Asian J Endosc Surg (2011) 4(3):143–6.10.1111/j.1758-5910.2011.00081.x22776279
62. Tomishige H, Morise Z, Kawabe N, Nagata H, Ohshima H, Kawase J, et al. Caudal approach to pure laparoscopic posterior sectionectomy under the laparoscopy-specific view. World J Gastrointest Surg (2013) 5(6):173–7.10.4240/wjgs.v5.i6.17323977419
63. Torzilli G, Belghiti J, Kokudo N, Takayama T, Capussotti L, Nuzzo G, et al. A snapshot of the effective indications and results of surgery for hepatocellular carcinoma in tertiary referral centers: is it adherent to the EASL/AASLD recommendations?: an observational study of the HCC East-West study group. Ann Surg (2013) 257:929–37.10.1097/SLA.0b013e31828329b8
64. Imamura H, Matsuyama Y, Tanaka E, Ohkubo T, Hasegawa K, Miyagawa S, et al. Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy. J Hepatol (2003) 38:200–7.10.1016/S0168-8278(02)00360-412547409
65. Hoshida Y, Villanueva A, Kobayashi M, Peix J, Chiang DY, Camargo A, et al. Gene expression in fixed tissues and outcome in hepatocellular carcinoma. N Engl J Med (2008) 359:1995–2004.10.1056/NEJMoa080452518923165
66. Zhou WP, Lai EC, Li AJ, Fu SY, Zhou JP, Pan ZY, et al. A prospective, randomized, controlled trial of preoperative transarterial chemoembolization for resectable large hepatocellular carcinoma. Ann Surg (2009) 249:195–202.10.1097/SLA.0b013e3181961c1619212170
67. Lau WY, Leung TW, Ho SK, Chan M, Machin D, Lau J, et al. Adjuvant intra-arterial iodine-131-labelled lipiodol for resectable hepatocellular carcinoma: a prospective randomised trial. Lancet (1999) 353:797–801.10.1016/S0140-6736(98)06475-710459961
68. Takayama T, Sekine T, Makuuchi M, Yamasaki S, Kosuge T, Yamamoto J, et al. Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial. Lancet (2000) 356:802–7.10.1016/S0140-6736(00)02654-411022927
69. Muto Y, Moriwaki H, Ninomiya M, Adachi S, Saito A, Takasaki KT, et al. Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma. Hepatoma Prevention Study Group. N Engl J Med (1996) 334:1561–7.10.1056/NEJM1996061333424028628336
70. Breitenstein S, Dimitroulis D, Petrowsky H, Puhan MA, Mullhaupt B, Clavien PA. Systematic review and meta-analysis of interferon after curative treatment of hepatocellular carcinoma in patients with viral hepatitis. Br J Surg (2009) 96:975–81.10.1002/bjs.673119672926
71. Shen YC, Hsu C, Chen LT, Cheng CC, Hu FC, Cheng AL. Adjuvant interferon therapy after curative therapy for hepatocellular carcinoma (HCC): a meta-regression approach. J Hepatol (2010) 52:889–94.10.1016/j.jhep.2009.12.04120395009
72. Lau WY. Management of hepatocellular carcinoma. J R Coll Surg Edinb (2002) 47:389–99.11874260
73. Luo YQ, Wang Y, Chen H, Wu MC. Influence of preoperative transcatheter arterial chemoembolization on liver resection in patients with resectable hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int (2002) 1: 523–6.14607679
74. Schwartz JD, Schwartz M, Mandeli J, Sung M. Neoadjuvant and adjuvant therapy for resectable hepatocellular carcinoma: review of the randomised clinical trials. Lancet Oncol (2002) 3:593–603.10.1016/S1470-2045(02)00873-212372721
75. Poon RT, Fan ST, O’Suilleabhain CB, Wong J. Aggressive management of patients with extrahepatic and intrahepatic recurrences of hepatocellular carcinoma by combined resection and locoregional therapy. J Am Coll Surg (2002) 195:311–8.10.1016/S1072-7515(02)01226-712229937
76. Minagawa M, Makuuchi M, Takayama T, Kokudo N. Selection criteria for repeat hepatectomy in patients with recurrent hepatocellular carcinoma. Ann Surg (2003) 238:703–10.10.1097/01.sla.0000094549.11754.e614578733
77. Asahara T, Itamoto T, Katayama K, Nakahara H, Hino H, Yano M, et al. Hepatic resection with tumor thrombectomy for hepatocellular carcinoma with tumor thrombi in the major vasculature. Hepatogastroenterology (1999) 46:1862–9.10430360
78. Ohkubo T, Yamamoto J, Sugawara Y, Shimada K, Yamasaki S, Makuuchi M, et al. Surgical results for hepatocellular carcinoma with macroscopic portal vein thrombosis. J Am Coll Surg (2000) 191:657–60.10.1016/S1072-7515(00)00740-711129815
79. Lee HS, Kim JS, Choi IJ, Chung JW, Park JH, Kim CY. The safety and efficacy of transcatheter arterial chemoembolization in the treatment of patients with hepatocellular carcinoma and main portal vein obstruction: a prospective controlled study. Cancer (1997) 79:2087–94.9179054
80. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med (1996) 334:693–700.10.1056/NEJM1996031433411048594428
81. Poon RT, Fan ST, Ng IO, Wong J. Prognosis after hepatic resection for stage IVA hepatocellular carcinoma: a need for reclassification. Ann Surg (2003) 237:376–83.10.1097/01.SLA.0000055224.68432.8012616122
82. Ikai I, Yamaoka Y, Yamamoto Y, Ozaki N, Sakai Y, Satoh S, et al. Surgical intervention for patients with stage IV-A hepatocellular carcinoma without lymph node metastasis proposal as a standard therapy. Ann Surg (1998) 227:433–9.10.1097/00000658-199803000-000169527067
83. Shi J, Lai EC, Li N, Guo WX, Xue J, Lau WY, et al. Surgical treatment for hepatocellular carcinoma with portal vein tumor thrombus. Ann Surg Oncol (2010) 17:2073–80.10.1245/s10434-010-0940-420131013
84. Tazawa J, Maeda M, Sakai Y, Yamane M, Ohbayashi H, Kakinuma S, et al. Radiation therapy in combination with transcatheter arterial chemoembolization for hepatocellular carcinoma with extensive portal vein involvement. J Gastroenterol Hepatol (2001) 16:660–5.10.1046/j.1440-1746.2001.02496.x11422619
85. Ishikura S, Ogino T, Furuse J, Satake M, Baba S, Kawashima M, et al. Radiotherapy after transcatheter arterial chemoembolization for patients with hepatocellular carcinoma and portal vein tumor thrombus. Am J Clin Oncol (2002) 25:189–93.10.1097/00000421-200204000-0001911943901
86. Minagawa M, Makuuchi M, Takayama T, Ohtomo K. Selection criteria for hepatectomy in patients with hepatocellular carcinoma and portal vein tumor thrombus. Ann Surg (2001) 233:379–84.10.1097/00000658-200103000-0001211224626
87. Peng BG, He Q, Li JP, Zhou F. Adjuvant transcatheter arterial chemoembolization improves efficacy of hepatectomy for patients with hepatocellular carcinoma and portal vein tumor thrombus. Am J Surg (2009) 198:313–8.10.1016/j.amjsurg.2008.09.02619285298
88. Sakon M, Nagano H, Dono K, Nakamori S, Umeshita K, Yamada A, et al. Combined intraarterial 5-fluorouracil and subcutaneous interferon-α therapy for advanced hepatocellular carcinoma with tumor thrombi in the major portal branches. Cancer (2002) 94:435–42.10.1002/cncr.1024611900229
89. Ota H, Nagano H, Sakon M, Eguchi H, Kondo M, Yamamoto T, et al. Treatment of hepatocellular carcinoma with major portal vein thrombosis by combined therapy with subcutaneous interferon-alpha and intra-arterial 5-fluorouracil; role of type 1 interferon receptor expression. Br J Cancer (2005) 93:57–64.10.1038/sj.bjc.660274216106266
90. Nagano H, Wada H, Kobayashi S, Marubashi S, Eguchi H, Tanemura M, et al. Long-term outcome of combined interferon-α and 5-fluorouracil treatment for advanced hepatocellular carcinoma with major portal vein thrombosis. Oncology (2011) 80(1–2):63–9.10.1159/00032828121659784
91. Nagano H, Sakon M, Eguchi H, Kondo M, Yamamoto T, Ota H, et al. Hepatic resection followed by IFN-alpha and 5-FU for advanced hepatocellular carcinoma with tumor thrombus in the major portal branch. Hepatogastroenterology (2007) 54:172–9.17419255
92. Morise Z, Sugioka A, Fujita J, Hoshimoto S, Kato T, Ikeda M. S-1 plus cisplatin combination therapy for the patients with primary liver carcinomas. Hepatogastroenterology (2007) 54:2315–8.18265655
93. Morise Z, Sugioka A, Kato R, Fujita J, Hoshimoto S, Kato T. Transarterial chemoembolization with degradable starch microspheres, irinotecan, and mitomycin-C in patients with liver metastases. J Gastrointest Surg (2006) 10(2):249–58.10.1016/j.gassur.2005.08.00416455458
94. Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet (2003) 362:1907–17.10.1016/S0140-6736(03)14964-114667750
95. Bruix J, Sherman M, Practice Guidelines Committee, American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma. Hepatology (2005) 42:1208–36.10.1002/hep.20933
96. Bruix J, Sherman M, American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma: an update. Hepatology (2011) 53:1020–2.10.1002/hep.24199
97. Llovet JM, Fuster J, Bruix J. Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation. Hepatology (1999) 30:1434–40.10.1002/hep.51030062910573522
98. Yao FY, Bass NM, Nikolai B, Davern TJ, Kerlan R, Wu V, et al. Liver transplantation for hepatocellular carcinoma: analysis of survival according to the intention-to-treat principle and dropout from the waiting list. Liver Transpl (2002) 8:873–83.10.1053/jlts.2002.3492312360427
99. Belghiti J, Cortes A, Abdalla EK, Régimbeau JM, Prakash K, Durand F, et al. Resection prior to liver transplantation for hepatocellular carcinoma. Ann Surg (2003) 238:885–92.10.1097/01.sla.0000098621.74851.6514631225
100. Cherqui D, Laurent A, Mocellin N, Tayar C, Luciani A, Van Nhieu JT, et al. Liver resection for transplantable hepatocellular carcinoma: long-term survival and role of secondary liver transplantation. Ann Surg (2009) 250:738–46.10.1097/SLA.0b013e3181bd582b19801927
101. Del Gaudio M, Ercolani G, Ravaioli M, Cescon M, Lauro A, Vivarelli M, et al. Liver transplantation for recurrent hepatocellular carcinoma on cirrhosis after liver resection: University of Bologna experience. Am J Transplant (2008) 8:1177–85.10.1111/j.1600-6143.2008.02229.x18444925
102. Cucchetti A, Vitale A, Gaudio MD, Pinna AD. Harm and benefits of primary liver resection and salvage transplantation for hepatocellular carcinoma. Am J Transplant (2010) 10:619–27.10.1111/j.1600-6143.2009.02984.x20121741
103. Majno PE, Sarasin FP, Mentha G, Hadengue A. Primary liver resection and salvage transplantation or primary liver transplantation in patients with single, small hepatocellular carcinoma and preserved liver function: an outcome-oriented decision analysis. Hepatology (2000) 31:899–906.10.1053/he.2000.576310733546